Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cmx 157
2. Cmx-157
3. Cmx157
4. Hdp-tenofovir
5. Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine
1. 911208-73-6
2. Hdp-tenofovir
3. Cmx157
4. Cmx-157
5. 3-(hexadecyloxy)propyl Hydrogen ((((r)-1-(6-amino-9h-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate
6. Cmx 157
7. K7j545mema
8. 9-r-(2-(phosphonomethoxy)propyl)adenine
9. Phosphonic Acid, (((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-, Mono(3-(hexadecyloxy)propyl) Ester
10. Hexadecyloxypropyl Tenofovir
11. Unii-k7j545mema
12. Phosphonic Acid, [[(1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy]methyl]-, Mono[3-(hexadecyloxy)propyl] Ester
13. Hdp-pmpa
14. Hdp-(r)-pmpa
15. Tenofovir Exalidex(cmx157)
16. Chembl515564
17. Schembl2299893
18. Tenofovir Exalidex [inn]
19. Bdbm77092
20. Tenofovir Exalidex [who-dd]
21. Hexadecyloxypropyl Ester Of Tenofovir
22. Zinc42875215
23. Db14925
24. Hy-109014
25. Cs-0030512
26. J3.616.616i
27. Q27282054
28. Hexadecyloxypropyl 9-(2-(phosphonomethoxy)propyl)adenine
29. [(1r)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-(3-hexadecoxypropoxy)phosphinic Acid
30. [(2r)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(3-hexadecoxypropoxy)phosphinic Acid
31. 3-(hexadecyloxy)propyl Hydrogen ((((2r)-1-(6-amino-9h-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate
32. 3-(hexadecyloxy)propylhydrogen((((r)-1-(6-amino-9h-purin-9-yl)propan-2-yl)oxy)methyl)phosphonate
33. Phosphonic Acid, P-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-, Mono(3(hexadecyloxy)propyl) Ester
34. Phosphonic Acid, P-(((1r)-2-(6-amino-9h-purin-9-yl)-1-methylethoxy)methyl)-, Mono(3-(hexadecyloxy)propyl) Ester
| Molecular Weight | 569.7 g/mol |
|---|---|
| Molecular Formula | C28H52N5O5P |
| XLogP3 | 6.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 25 |
| Exact Mass | 569.37060677 g/mol |
| Monoisotopic Mass | 569.37060677 g/mol |
| Topological Polar Surface Area | 135 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 650 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-HIV Agents
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
ABOUT THIS PAGE
A Tenofovir Exalidex manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tenofovir Exalidex, including repackagers and relabelers. The FDA regulates Tenofovir Exalidex manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tenofovir Exalidex API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tenofovir Exalidex supplier is an individual or a company that provides Tenofovir Exalidex active pharmaceutical ingredient (API) or Tenofovir Exalidex finished formulations upon request. The Tenofovir Exalidex suppliers may include Tenofovir Exalidex API manufacturers, exporters, distributors and traders.
Tenofovir Exalidex Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tenofovir Exalidex GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tenofovir Exalidex GMP manufacturer or Tenofovir Exalidex GMP API supplier for your needs.
A Tenofovir Exalidex CoA (Certificate of Analysis) is a formal document that attests to Tenofovir Exalidex's compliance with Tenofovir Exalidex specifications and serves as a tool for batch-level quality control.
Tenofovir Exalidex CoA mostly includes findings from lab analyses of a specific batch. For each Tenofovir Exalidex CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tenofovir Exalidex may be tested according to a variety of international standards, such as European Pharmacopoeia (Tenofovir Exalidex EP), Tenofovir Exalidex JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tenofovir Exalidex USP).
LOOKING FOR A SUPPLIER?
